Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region


#132971

85pages

GBI Research

$ 1000

In Stock


GBI Researchs report, Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region" provides detailed insight into the Americas API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and CMO growth in the region and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Americas API market, covering all the major parameters. 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts. 

Americas is the second largest regional market for APIs by revenue in the world. Americas active pharmaceutical ingredients (API) market revenue held a share of around 42.5% of global API market revenue of 108.6 $ billion in 2011. Total revenue generated by the Americas API market was $46.1 billion in 2011 and is expected to grow at a CAGR of 5.6% to reach $63.8 billion by 2017.This will be supported by healthy demand from biotech and generic API sectors.

Scope

  • Market revenue data for APIs from 2005 to 2011 and forecast for six years to 2017. 
  • API markets in key countries in the region: North America ,South and Central America and key countries like the US and Canada
  • API industry structure and market trends such as a shift in manufacturing and growth in biotechnology for the Americas region. 
  • Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and government initiatives like price reimbursement cut.
  • Detailed historical, forecast trend and share analysis of API revenue based on product types (Synthetic and Biotech APIs) in the Americas market and in key countries of the region. 
  • Detailed historical, forecast trend and share analysis of API revenue based on customer base (Generic and Innovative for Synthetic APIs) (Biosimilars and biologics for Biotech Apis) in the Americas market and in key countries of the region. 
  • Analysis of API revenue based on therapeutic categories in the North America ,South and Central America

Reasons to buy

  • Develop business strategies with the help of specific insights on the Americas API market. 
  • Identify opportunities and challenges in the Americas API market. 
  • Invest in the growing segments of the API market. 
  • Increase future revenue and profitability with the help of insights on the future opportunities and critical success factors in the Americas API market. 
  • Benchmark your operations and strategies against the major players in the global API market

Keywords

API, Generic API, Branded API, Biotech, generic, innovator drug, therapeutic, Biologics, Biosimilars